These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9759991)

  • 21. Comparison of the antianginal efficacy of isosorbide dinitrate (ISDN) 40 mg and verapamil 120 mg three times daily in the acute trial and following two-week treatment.
    Schneider W; Maul FD; Bussmann WD; Lang E; Hör G; Kaltenbach M
    Eur Heart J; 1988 Feb; 9(2):149-58. PubMed ID: 3280317
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Role of nitrates in pharmacologic modulation of reflected waves and their significance in the treatment of arterial hypertension in the elderly].
    Felizardo A; Maldonado J; Pego M; Teixeira F; Providência LA
    Rev Port Cardiol; 1997; 16(7-8):607-11, 587. PubMed ID: 9432207
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nitrate tolerance: hemodynamic effects of intravenous isosorbide dinitrate after sustained oral isosorbide dinitrate administration.
    Kumagae H; Koiwaya Y; Tanaka K
    Clin Ther; 1990; 12(1):31-43. PubMed ID: 2328526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isosorbide dinitrate ointment in Raynaud's disease.
    Diehm C; Müller-Bühl U; Mörl H
    Z Kardiol; 1983; 72 Suppl 3():185-7. PubMed ID: 6364591
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of the vasodilator isosorbide dinitrate on ocular circulation].
    Hessemer V; Schmidt KG
    Klin Monbl Augenheilkd; 1996 Mar; 208(3):188-95. PubMed ID: 8699777
    [TBL] [Abstract][Full Text] [Related]  

  • 26. What intervals in oral therapy of isosorbide dinitrate in various doses are sufficient to prevent nitrate tolerance?
    Kośmicki M; Sadowski Z; Szwed H; Kowalik I
    Med Sci Monit; 2000; 6(4):763-8. PubMed ID: 11208406
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isosorbide Dinitrate, With or Without Hydralazine, Does Not Reduce Wave Reflections, Left Ventricular Hypertrophy, or Myocardial Fibrosis in Patients With Heart Failure With Preserved Ejection Fraction.
    Zamani P; Akers S; Soto-Calderon H; Beraun M; Koppula MR; Varakantam S; Rawat D; Shiva-Kumar P; Haines PG; Chittams J; Townsend RR; Witschey WR; Segers P; Chirinos JA
    J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28219917
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of isosorbide dinitrate on placental blood flow and maternal blood pressure in women with pregnancy induced hypertension.
    Thaler I; Amit A; Kamil D; Itskovitz-Eldor J
    Am J Hypertens; 1999 Apr; 12(4 Pt 1):341-7. PubMed ID: 10232493
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early hemodynamic effects at rest with acute and chronic isosorbide dinitrate treatment in patients with ischemic heart disease.
    Jørgensen LH; Thaulow E; Refsum HE
    Clin Cardiol; 1995 Aug; 18(8):455-9. PubMed ID: 7586763
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Double-blind randomized multicenter study on the efficacy of trapidil versus isosorbide dinitrate in stable angina pectoris.
    Raubach KH; Vlahov V; Wolter K; Bussmann WD
    Clin Cardiol; 1997 May; 20(5):483-8. PubMed ID: 9134282
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of glyceryl trinitrate on venous and arterial effects of chronic, asymmetric isosorbide dinitrate treatment in patients with ischemic heart disease.
    Jørgensen LH; Refsum HE; Thaulow E
    Clin Cardiol; 1994 Feb; 17(2):65-70. PubMed ID: 8162628
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tolerance to isosorbide dinitrate: rate of development and reversal.
    Parker JO; Fung HL; Ruggirello D; Stone JA
    Circulation; 1983 Nov; 68(5):1074-80. PubMed ID: 6616789
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hemodynamic study of the development of tolerance in intravenous nitrate therapy].
    Unverdorben M; Pfeiffer F; Kunkel B; Bachmann K
    Z Kardiol; 1989; 78 Suppl 2():88-94; discussion 115-7. PubMed ID: 2686259
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A multicenter, 14-week study of telmisartan and ramipril in patients with mild-to-moderate hypertension using ambulatory blood pressure monitoring.
    Lacourcière Y; Neutel JM; Davidai G; Koval S
    Am J Hypertens; 2006 Jan; 19(1):104-12. PubMed ID: 16461201
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ambulatory blood pressure response to once-daily fimasartan: an 8-week, multicenter, randomized, double-blind, active-comparator, parallel-group study in Korean patients with mild to moderate essential hypertension.
    Lee H; Kim KS; Chae SC; Jeong MH; Kim DS; Oh BH
    Clin Ther; 2013 Sep; 35(9):1337-49. PubMed ID: 23932463
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Combination therapy with isosorbide dinitrate and verapamil in patients with coronary heart disease and hypertension: effect on blood pressure, ischemia and left ventricular function].
    Vogler AC; Silber S; Vogel M; Theisen K
    Z Kardiol; 1989; 78 Suppl 2():183-7; discussion 188-9. PubMed ID: 2588761
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pre- and afterload reduction in chronic mitral regurgitation: a double-blind randomized placebo-controlled trial of the acute and 2 weeks' effect of nifedipine or isosorbide dinitrate treatment on left ventricular function and the severity of mitral regurgitation.
    Kelbaek H; Aldershvile J; Skagen K; Hildebrandt P; Nielsen SL
    Br J Clin Pharmacol; 1996 Jun; 41(6):493-7. PubMed ID: 8799512
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contribution of isosorbide-5-mononitrate, a major metabolite of isosorbide dinitrate (ISDN), to the hemodynamic effect of ISDN administered orally in conscious dogs.
    Kogi K; Satoh T
    Jpn J Pharmacol; 1987 Jul; 44(3):249-57. PubMed ID: 3656782
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of the efficacy and duration of action of candesartan cilexetil and losartan as assessed by clinic and ambulatory blood pressure after a missed dose, in truly hypertensive patients: a placebo-controlled, forced titration study. Candesartan/Losartan study investigators.
    Lacourcière Y; Asmar R
    Am J Hypertens; 1999 Dec; 12(12 Pt 1-2):1181-7. PubMed ID: 10619580
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Plasma volume expansion may explain the attenuation of antianginal activity of oral isosorbide dinitrate in long-term therapy].
    Kośmicki M; Sadowski Z
    Pol Arch Med Wewn; 1999 Nov; 102(5):967-72. PubMed ID: 11072531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.